SEVEN EIGHT CAPITAL, LP
SEVEN EIGHT CAPITAL, LP latest Q4_2020 13F filings reported $439,623,000 in market value on this 2021-02-09 report date . The portfolio quarterly return is -4.97%. This fund has 385 securities concentrations of 100% weights.
SEVEN EIGHT CAPITAL, LP largest holding is Alexion Pharmaceuticals Inc. with weight of 1.02% and $4,502,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.
Portfolio Performance History
FILE DATE | REPORT PERIOD | QTR YEAR | FILE TYPE | NOS. OF STOCKS | REPORTED VALUE | RETURN |
---|---|---|---|---|---|---|
2021-02-09 | 2020-12-31 | Q4_2020 | 13F-HR | 385 | $439,623,000 | -4.97% |
2020-11-16 | 2020-09-30 | Q3_2020 | 13F-HR | 529 | $462,614,000 | 238.56% |
2020-08-06 | 2020-06-30 | Q2_2020 | 13F-HR | 304 | $136,640,000 | -64.87% |
2020-05-14 | 2020-03-31 | Q1_2020 | 13F-HR | 434 | $388,916,000 | -79.39% |
2020-02-13 | 2019-12-31 | Q4_2019 | 13F-HR | 607 | $1,886,698,000 | -0.41% |
2019-11-14 | 2019-09-30 | Q3_2019 | 13F-HR | 572 | $1,894,527,000 | -0.03% |
2019-08-12 | 2019-06-30 | Q2_2019 | 13F-HR | 556 | $1,895,023,000 | 0.11% |
2019-05-15 | 2019-03-31 | Q1_2019 | 13F-HR | 531 | $1,892,977,000 | 6.11% |
2019-02-14 | 2018-12-31 | Q4_2018 | 13F-HR | 521 | $1,783,916,000 | 8.16% |
2018-10-18 | 2018-09-30 | Q3_2018 | 13F-HR | 550 | $1,649,385,000 | 14.70% |
2018-08-07 | 2018-06-30 | Q2_2018 | 13F-HR | 446 | $1,438,044,000 | 18.32% |
2018-05-14 | 2018-03-31 | Q1_2018 | 13F-HR | 341 | $1,215,375,000 | 24.08% |
2018-02-12 | 2017-12-31 | Q4_2017 | 13F-HR | 435 | $979,493,000 | 19.61% |
2017-10-16 | 2017-09-30 | Q3_2017 | 13F-HR | 425 | $818,903,000 | 17.61% |
2017-08-10 | 2017-06-30 | Q2_2017 | 13F-HR | 542 | $696,314,000 | 34.97% |
2017-05-15 | 2017-03-31 | Q1_2017 | 13F-HR | 505 | $515,893,000 | 3.61% |
2017-02-14 | 2016-12-31 | Q4_2016 | 13F-HR | 559 | $497,924,000 | 45.48% |
2016-11-14 | 2016-09-30 | Q3_2016 | 13F-HR | 328 | $342,263,000 | 17.55% |
2016-08-12 | 2016-06-30 | Q2_2016 | 13F-HR | 534 | $291,157,000 | 23.91% |